Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.
Raje N, Vescio R, Montgomery CW, Badros A, Munshi N, Orlowski R, Hadala JT, Warsi G, Argonza-Aviles E, Ericson SG, Anderson KC. Raje N, et al. Among authors: vescio r. Clin Cancer Res. 2016 Mar 15;22(6):1378-84. doi: 10.1158/1078-0432.CCR-15-1864. Epub 2015 Dec 7. Clin Cancer Res. 2016. PMID: 26644410 Clinical Trial.
Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.
Berenson JR, Yang HH, Vescio RA, Nassir Y, Mapes R, Lee SP, Wilson J, Yellin O, Morrison B, Hilger J, Swift R. Berenson JR, et al. Among authors: vescio ra. Ann Hematol. 2008 Aug;87(8):623-31. doi: 10.1007/s00277-008-0501-0. Epub 2008 May 8. Ann Hematol. 2008. PMID: 18463870 Clinical Trial.
Recent advances in the treatment of multiple myeloma.
Henick K, Vescio RA, Berenson JR. Henick K, et al. Among authors: vescio ra. Curr Opin Hematol. 1998 Jul;5(4):254-8. doi: 10.1097/00062752-199807000-00004. Curr Opin Hematol. 1998. PMID: 9747631 Review.
HHV-8 is present in multiple myeloma patients.
Berenson JR, Vescio RA. Berenson JR, et al. Among authors: vescio ra. Blood. 1999 May 15;93(10):3157-9; discussion 3164-6. Blood. 1999. PMID: 10233867 Free article. Review. No abstract available.
Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Berenson JR, Yang HH, Sadler K, Jarutirasarn SG, Vescio RA, Mapes R, Purner M, Lee SP, Wilson J, Morrison B, Adams J, Schenkein D, Swift R. Berenson JR, et al. Among authors: vescio ra. J Clin Oncol. 2006 Feb 20;24(6):937-44. doi: 10.1200/JCO.2005.03.2383. Epub 2006 Jan 17. J Clin Oncol. 2006. PMID: 16418495 Clinical Trial.
119 results